This page serves as the chronological archive of all MarketSpeaker content, organizing published material by date rather than topic or format. It aggregates news, briefs, guides, and other editorial outputs into a time-based structure, allowing readers to track coverage across specific periods. Designed for researchers, analysts, and returning readers, the archive provides a clear historical view of market narratives and reporting cycles. Unlike category or tag pages, it emphasizes temporal navigation over thematic grouping.
X has expanded access to X Money for select Premium subscribers in the United States, introducing digital payments and FDIC insurance coverage of up to $10 million.
Airwallex raised $320 million at an $11 billion valuation as the fintech company expands its financial infrastructure for a future where AI agents manage business payments and finance.
SpaceX plans to launch a direct-to-consumer Starlink mobile service in the United States, expanding beyond satellite broadband into the highly competitive wireless market.
Apple increased prices across several Mac, iPad, Vision Pro, and home device products, citing unprecedented cost inflation driven by a global memory shortage.
Micron reported record quarterly revenue, earnings, and guidance, significantly exceeding Wall Street expectations as surging demand for AI memory chips continued to drive growth.
Wendy’s shares surged 42% after attracting heavy attention from WallStreetBets, with record short interest fueling speculation that the stock could become the market’s next major short squeeze.
OpenAI introduced Jalapeño, a custom AI inference chip developed with Broadcom and designed to improve the efficiency and performance of running large language models.
Y Combinator co-founder Paul Graham argues that building a billion-dollar business is possible through sustained growth, identifying overlooked customer needs, and creating products founders genuinely want themselves.
Cboe has launched Cboe Predicts, a new prediction market platform that allows traders to take directional positions on future market outcomes through regulated exchange-traded products.
Gero has secured $17 million in new funding, bringing its total capital raised to $34 million as the company advances AI-driven drug discovery focused on aging and chronic diseases.